Status:
UNKNOWN
Identification by Transcriptomic Approach of New Prognostic and Predictive Markers in a Cohort of Atypical Meningiomas
Lead Sponsor:
Central Hospital, Nancy, France
Collaborating Sponsors:
Institut National de la Santé Et de la Recherche Médicale, France
Conditions:
Meningioma Atypical
Eligibility:
All Genders
18+ years
Brief Summary
Determine by a transcriptomic approach new prognostic and predictive markers in atypical meningiomas (WHO grade II). Retrospective observational study, on a cohort of 85 atypical meningiomas. Transcr...
Eligibility Criteria
Inclusion
- Primary operated patients for an atypical meningioma (WHO grade II) in the Neurosurgery department of the University Hospital of Nancy.
- At least one postoperative follow-up visit.
- Adult patients (\>18 yo) at the time of the intervention.
- Surgical excision.
Exclusion
- History of meningioma in the same location.
- Neo-adjuvant treatment.
- Absence of non-objection form.
Key Trial Info
Start Date :
February 25 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 31 2023
Estimated Enrollment :
85 Patients enrolled
Trial Details
Trial ID
NCT05259332
Start Date
February 25 2022
End Date
October 31 2023
Last Update
February 28 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Guillaume GAUCHOTTE
Vandœuvre-lès-Nancy, Lorraine, France, 54511